Free Trial

Dakota Wealth Management Has $3.47 Million Stake in Tempus AI, Inc. $TEM

Tempus AI logo with Medical background

Key Points

  • Dakota Wealth Management increased its stake in Tempus AI, Inc. by 67.8% in Q2, now holding shares worth approximately $3.47 million.
  • CEO Eric P. Lefkofsky sold 332,500 shares for over $24.6 million, marking a decrease in his overall holdings by 3.49%.
  • Tempus AI reported a 89.5% year-over-year revenue increase in its latest earnings, reaching $314.64 million, and beat EPS estimates by $0.01.
  • Five stocks we like better than Tempus AI.

Dakota Wealth Management raised its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 67.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 54,572 shares of the company's stock after acquiring an additional 22,056 shares during the period. Dakota Wealth Management's holdings in Tempus AI were worth $3,467,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in TEM. BNP Paribas Financial Markets acquired a new position in shares of Tempus AI during the 4th quarter worth about $78,000. ProShare Advisors LLC bought a new position in Tempus AI in the 4th quarter worth approximately $244,000. Two Sigma Advisers LP bought a new position in Tempus AI in the 4th quarter worth approximately $625,000. GAMMA Investing LLC acquired a new position in shares of Tempus AI during the first quarter worth approximately $105,000. Finally, James J. Burns & Company LLC boosted its position in shares of Tempus AI by 71.4% in the first quarter. James J. Burns & Company LLC now owns 12,000 shares of the company's stock valued at $579,000 after acquiring an additional 5,000 shares during the period. 24.22% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Eric P. Lefkofsky sold 332,500 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $74.10, for a total value of $24,638,250.00. Following the completion of the transaction, the chief executive officer directly owned 9,207,533 shares of the company's stock, valued at approximately $682,278,195.30. This represents a 3.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 17,460 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the sale, the chief operating officer directly owned 839,180 shares in the company, valued at approximately $62,644,787. This represents a 2.04% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 601,787 shares of company stock worth $42,492,268. Insiders own 26.27% of the company's stock.

Tempus AI Trading Down 2.4%

Shares of TEM stock opened at $77.33 on Friday. The firm has a fifty day moving average of $72.30 and a 200-day moving average of $61.59. The stock has a market cap of $13.43 billion, a price-to-earnings ratio of -64.98 and a beta of 5.08. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $97.79. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. During the same period in the previous year, the business earned ($6.86) EPS. The firm's revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, equities research analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

TEM has been the topic of a number of research reports. Bank of America boosted their target price on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Guggenheim boosted their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Needham & Company LLC reissued a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th. Finally, BTIG Research boosted their price target on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research note on Wednesday, August 20th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Tempus AI has an average rating of "Moderate Buy" and an average price target of $70.17.

Check Out Our Latest Stock Analysis on TEM

Tempus AI Company Profile

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Stories

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

America Is Rebuilding — 3 Stocks Set to Soar
The Nuclear Solution: 5 Must-Know Plays for the AI Energy Surge
AI vs. Wall Street: 5 Names It Loves Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines